HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Santhosh Kumar Chitlimalla Selected Research

2- methyl- 2- ((1- (3- phenyl- 7- propylbenzo(d)isoxazol- 6- yl)oxy)propyl)- 1H- 4- indolyloxypropanoic acid

2/2008A novel peroxisome proliferator-activated receptor alpha/gamma agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Santhosh Kumar Chitlimalla Research Topics

Disease

1Ataxia Telangiectasia (Louis Bar Syndrome)
02/2008
1Diabetes Mellitus
02/2008
1Mouth Neoplasms (Oral Cancer)
02/2008
1Neoplasms (Cancer)
02/2008

Drug/Important Bio-Agent (IBA)

1trioctyl phosphine oxide (TOPO)IBA
02/2008
12- methyl- 2- ((1- (3- phenyl- 7- propylbenzo(d)isoxazol- 6- yl)oxy)propyl)- 1H- 4- indolyloxypropanoic acidIBA
02/2008
1PPAR-gamma AgonistsIBA
02/2008
1DNA (Deoxyribonucleic Acid)IBA
02/2008
1Type II DNA Topoisomerases (Topoisomerase II)IBA
02/2008
1Etoposide (VP 16)FDA LinkGeneric
02/2008
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2008
1PPAR alphaIBA
02/2008